Clinical Trials Logo

Clinical Trial Summary

The two-stage protocol is gold standard in terms of infection control treating prosthetic joint infections of total hip and total knee arthroplasty. The antibiotic pause for diagnostic reasons before reconstruction (stage two) is discussed concerning persistence of infection and development of resistant bacterial strains. Serological markers and synovial analysis are common use to exclude persistence of infection.

The investigators therefore asked 1) is the serological testing of c-reactive protein and leukocytes a valuable tool to predict a persistence of infection and 2) what is the role of synovial aspiration of PMMA Spacers on hip and knee joints.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03038464
Study type Observational
Source Technische Universität München
Contact norbert harrasser
Phone 15232716657
Email norbert.harrasser@gmx.net
Status Recruiting
Phase N/A
Start date November 1, 2016
Completion date May 1, 2019